Faderl S, Kantarjian H M, Talpaz M. Chronic myelogenous leukemia:？？ update on biology and treatment[J]. Oncology (Williston Park), 1999, 13(2):？ 169-180. [2]Mauro M J, Deininger M W. Chronic myeloid leukemia in 2006:？？ a perspective[J]. Haematologica, 2006, 91(2):？ 152. [3]Rowe J M. Closing the gap in CML[J]. Blood, 2007, 109(6):？ 2271. [4]Meltzer P S. Cancer genomics:？？ small RNAs with big impacts[J]. Nature, 2005, 435(7043):？？ 754-746. [5]Yamamoto M, Kurosu T, Kakihana K, et al. The two major imatinib resistance mutations E255K and T315I enhance the activity of BCR/ABL fusion kinase[J]. Biochem Biophys Res Commun, 2004, 319(4):？？ 1272-1275. [6]Hochhaus A, Kreil S, Corbin A S, et al. Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy[J]. Leukemia, 2002, 16(11): 2190-2196. [7]Carmell M A, Girard A, van-de-Kant H J, et al. MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male germline[J]. Dev Cell, 2007, 12(4):？？ 503-514. [8]Leivonen S K, Makela R, Ostling P, et al. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines[J]. Oncogene, 2009, 28(44):？ 3926-3936. [9]Li X F, Yan P J, Shao Z M. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer[J]. Oncogene, 2009, 28(44):？？ 3937-3948. [10]Chen J, Feilotter H E, Pare G C, et al. MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma[J]. Am J Pathol, 2010, 176(5):？ 2520-2529. [11]Chen J, Zhang X, Lentz C, et al. miR-193b Regulates Mcl-1 in Melanoma[J]. Am J Pathol, 2011, 179(5):？ 2162-2168. [12]Xu C, Liu S, Fu H, et al. MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells[J]. Eur J Cancer, 2010, 46(15):？？ 2828-2836. [13]Gao X N, Lin J, Gao L, et al. MicroRNA-193b regulates c-Kit proto-oncogene and represses cell proliferation in acute myeloid leukemia[J]. Leuk Res, 2011, 35(9):？？ 1226-1232. [14]Mets E, Van-der-Meulen J, Van-Peer G, et al. MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia[J]. Leukeimia, 2015, 29(4):？ 798-806. [15]Xie C, Jiang X H, Zhang J T, et al. CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer[J]. Oncogene, 2013, 32(18):？？ 2282-2291. [16]Mao K, Zhang J, He C, et al. Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib[J]. Cancer Lett, 2014, 352(2):？ 245-252. [17]Hu H, Li S, Liu J, et al. MicroRNA-193b modulates proliferation, migration, and invasion of non-small cell lung cancer cells[J]. Acta Biochim Biophys Sin (Shanghai), 2012, 44(5):？ 424-430.
[2]
杨永长,传良敏,黄文芳,等.辛伐他汀抑制K562细胞MAPK1、cyclin D1、E2F1、c-myc mRNA的表达[J].第三军医大学学报,2009,31(03):241. YANG Yong-chang,CHUAN Liang-min,HUANG Wen-fang,et al.Simvastatin down-regulates mRNA expressions of MAPK1, cyclin D1, E2F1 and c-myc in K562 cells[J].J Third Mil Med Univ,2009,31(19 ):241. [2]许晓风,李爽,李昊淼.K562细胞对树突状细胞线粒体功能和能量代谢状态的影响[J].第三军医大学学报,2015,37(18):1854. Xu Xiaofeng,Li Shuang,Li Haomiao.K562 cells impair mitochondrial function and energy metabolism of dendritic cells in Transwell coculture system[J].J Third Mil Med Univ,2015,37(19 ):1854. [3]周定安,黄文芳,刘文,等.P53途径在辛伐他汀诱导K562细胞凋亡中的作用[J].第三军医大学学报,2007,29(22):2160. ZHOU Ding-an,HUANG Wen-fang,LIU Wen,et al.Role of P53 pathway in simvastatin-induced apoptosis of K562 cells in vitro[J].J Third Mil Med Univ,2007,29(19 ):2160. [4]周定安,黄文芳,张明川,等.辛伐他汀对K562细胞PI3K-AKT信号通路分子变化影响的体内外比较[J].第三军医大学学报,2007,29(21):2049. ZHOU Ding-an,HUANG Wen-fang,ZHANG Ming-chuan,et al.Molecular changes of PI3K-AKT signal pathway in K562 cells treated with simvastatin in vitro and in vivo[J].J Third Mil Med Univ,2007,29(19 ):2049. [5]袁媛,李招权,司维柯,等.Wnt5a与髓细胞白血病发生关系的研究[J].第三军医大学学报,2007,29(21):2056. YUAN Yuan,LI Zhao-quan,SI Wei-ke,et al.Correlation between myeloid leukemia development and Wnt5a expression[J].J Third Mil Med Univ,2007,29(19 ):2056. [6]李招权,司维柯,邹全明,等.外源性Wnt5a激活K562细胞非经典Wnt5a/Ca2+信号途径研究[J].第三军医大学学报,2008,30(10):924. LI Zhao-quan,SI Wei-ke,ZOU Quan-ming,et al.Noncanonical Wnt5a/Ca2+ pathway activated by exogenous Wnt5a in K562 cells[J].J Third Mil Med Univ,2008,30(19 ):924. [7]何鹏,骆展鹏,张伶,等.RNAi重组体抑制白血病K562细胞系中NPM1基因的表达[J].第三军医大学学报,2008,30(10):938. HE Peng,LUO Zhan-peng,ZHANG Ling,et al.RNA interference silencing nucleophosmin 1 inhibits NPM1 gene expression in K562 cells[J].J Third Mil Med Univ,2008,30(19 ):938. [8]林雪梅,田雪莲,杨慧,等.青蒿琥酯对K562细胞和脐血CD34+造血干/祖细胞的选择性作用[J].第三军医大学学报,2007,29(20):1939. LIN Xue-mei,TIAN Xue-lian,YANG Hui,et al.Selective effect of artesunate on K562 cell and CD34+ hematopoietic stem/progenitor cell from umbilical cord blood[J].J Third Mil Med Univ,2007,29(19 ):1939. [9]罗颖,温贤浩,徐酉华.K562细胞survivin基因表达对淋巴细胞增殖和功能的影响[J].第三军医大学学报,2008,30(23):2215. LUO Ying,WEN Xian-hao,XU You-hua.Effect of enhanced survivin expression on lymphocyte proliferation and function in K562 cells[J].J Third Mil Med Univ,2008,30(19 ):2215. [10]史梅,冯文莉,王小中,等.靶向阻断STAT5对白血病K562细胞周期的影响[J].第三军医大学学报,2005,27(21):2118.
